A detailed history of Paloma Partners Management CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Paloma Partners Management CO holds 6,834 shares of EXAS stock, worth $348,055. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,834
Previous 4,482 52.48%
Holding current value
$348,055
Previous $189,000 146.03%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $99,795 - $166,592
2,352 Added 52.48%
6,834 $465,000
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $184,579 - $331,645
4,466 Added 27912.5%
4,482 $189,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $900 - $1,180
16 New
16 $1,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $1.13 Million - $2.41 Million
31,600 New
31,600 $1.25 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $3.47 Million - $4.97 Million
-60,200 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $4.36 Million - $6.06 Million
60,200 New
60,200 $4.69 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $249,322 - $370,736
-2,662 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $195,954 - $260,571
1,681 Added 171.36%
2,662 $351,000
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $3.86 Million - $5.51 Million
-38,779 Reduced 97.53%
981 $130,000
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $8.81 Million - $12.3 Million
-120,848 Reduced 75.24%
39,760 $4.05 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $8.95 Million - $14.9 Million
160,608 New
160,608 $14 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $250,632 - $690,661
-6,613 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $188,636 - $242,268
-2,429 Reduced 26.86%
6,613 $612,000
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $817,125 - $1.11 Million
9,042 New
9,042 $817,000
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $402,974 - $531,416
-4,502 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $279,033 - $434,443
4,502 New
4,502 $391,000
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $16.8 Million - $28.1 Million
-348,435 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $13.2 Million - $24.4 Million
348,435 New
348,435 $20.8 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $251,821 - $363,819
-6,324 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $294,002 - $382,665
6,324
6,324 $332,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.01B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.